Stroke and Carotid-Cerebral Vascular Disease After CABG
SCCAB
An Observational Cohort Study of Associations Between Early Neurological Complications(including Stroke)and Carotid-Cerebral Vascular Disease Among Patients After Coronary Artery Bypass Grafting
1 other identifier
observational
1,002
1 country
1
Brief Summary
Review the data of patients who underwent coronary artery bypass grafting (CABG) at the Department of Cardiovascular Surgery in Ruijin hospital from March 2020 to May 2022, including medical history, head and neck CTA, head CT scan, and early postoperative (within 7 days after surgery) neurological complications (defined as a composite of stroke, delayed awakening and severe delirium) . Case-control and retrospective cohorts were built to explore risk factors of early postoperative neurological complications, And its association with baseline carotid-cerebral vascular disease. Describe the epidemiological data of early postoperative neurological complications (stroke, delayed awakening, and severe delirium) after CABG surgery (within 7 days after surgery); explore independent risk factors of compound neurological complications, build predictive models; compare the effects of carotid-cerebral artery disease on early postoperative compound neurological complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2021
CompletedStudy Start
First participant enrolled
September 4, 2021
CompletedFirst Posted
Study publicly available on registry
September 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedDecember 12, 2024
December 1, 2024
1.4 years
September 1, 2021
December 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
the incidence of 7-day neurological complications
a composite of stroke, delayed awakening, severe delirium
within 7 days post-CABG
the incidence of 7-day stroke
including cerebral infarction, cerebral hemorrhage, and hypoxic-ischemic encephalopathy
within 7 days post-CABG
the incidence of delayed awakening
post-surgery patient does not wake up at 48 hours after withdrawing sedative
within 48 hours post-CABG
the incidence of severe delirium
ICU CAM-II score≥2 points
within 7 days post-CABG
Secondary Outcomes (4)
the incidence of All-cause death
7 days, 30 days and 1 year post-CABG
the incidence of CV-death
7 days, 30 days and 1 year post-CABG
the incidence of myocardial infraction
7 days, 30 days and 1 year post-CABG
the incidence of repeat revascularization
7 days, 30 days and 1 year post-CABG
Study Arms (2)
With moderate or severe carotid-cerebral artery disease
moderate (stenosis 50-69%) or severe (stenosis 70-100%) carotid-cerebral artery disease
Without moderate or severe carotid-cerebral artery disease
mild (stenosis 30-49%) or no (stenosis 0-29%) carotid-cerebral artery disease
Eligibility Criteria
Patients received CABG at the department of cardiac surgery in Ruijin hospital.
You may qualify if:
- Patients who received CABG at the department of cardiac surgery in our hospital.
- Surgery that patients received includes both isolated and combined CABG surgery.
- Includes both cardiopulmonary and non-cardiopulmonary bypass.
You may not qualify if:
- Without complete preoperative examination data, such as carotid-cerebral artery CTA, head CT imaging results and so on.
- Without complete baseline medical history and 7 day post-surgery record.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Study Sites (1)
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Study Officials
- PRINCIPAL INVESTIGATOR
Qiang Zhao, MD
Ruijin Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Director, Department of Cardiovascular Surgery, Vice President, Ruijin Hospital
Study Record Dates
First Submitted
September 1, 2021
First Posted
September 5, 2021
Study Start
September 4, 2021
Primary Completion
January 21, 2023
Study Completion
May 31, 2023
Last Updated
December 12, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share